Geron (GERN) Accumulated Depreciation (2011 - 2024)
Geron (GERN) posted Accumulated Depreciation of $1.7 million for Q4 2024, up 37.86% sequentially from $1.2 million in Q4 2023, and up 37.86% YoY from $1.2 million in Q1 2024.
Geron (GERN) Accumulated Depreciation (2011 - 2024) Analysis & Trends
Geron has reported Accumulated Depreciation for 14 years, with the latest figure at $1.7 million in Q4 2024.
- Quarterly Accumulated Depreciation rose 37.86% year-over-year to $1.7 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $1.7 million (up 37.86% YoY) and the FY2024 annual result came in at $1.7 million, up 37.86% from the prior year.
- Accumulated Depreciation climbed to $1.7 million in Q4 2024 per GERN's latest filing, from $1.2 million in the prior quarter.
- Over five years, Accumulated Depreciation peaked at $1.7 million in Q4 2024 and troughed at $613000.0 in Q4 2020.
- A 5-year average of $1.0 million and a median of $896000.0 in 2022 frame the typical range for Accumulated Depreciation.
- The sharpest annual moves came in 2020 and 2024: Accumulated Depreciation dropped 27.28% in 2020, then surged 37.86% in 2024.
- Over 5 years, Accumulated Depreciation stood at $613000.0 in 2020, then gained by 6.04% to $650000.0 in 2021, then soared by 37.85% to $896000.0 in 2022, then surged by 37.39% to $1.2 million in 2023, then surged by 37.86% to $1.7 million in 2024.
- According to Business Quant data, Accumulated Depreciation over the past three periods registered $1.7 million, $1.2 million, and $896000.0 for Q4 2024, Q4 2023, and Q4 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Geron | 1.02 Mn | -299.83 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1.70 Mn |
| Dec 31, 2023 | 1.23 Mn |
| Dec 31, 2022 | 896,000.00 |
| Dec 31, 2021 | 650,000.00 |
| Dec 31, 2020 | 613,000.00 |
| Dec 31, 2019 | 843,000.00 |
| Dec 31, 2018 | 779,000.00 |
| Dec 31, 2017 | 720,000.00 |
| Dec 31, 2016 | 1.21 Mn |
| Dec 31, 2015 | 1.25 Mn |
| Dec 31, 2014 | 1.19 Mn |
| Dec 31, 2013 | 1.19 Mn |
| Dec 31, 2012 | 12.48 Mn |
| Dec 31, 2011 | 17.30 Mn |